Eye-tracking treatment for stress symptoms in veterans with PTSD
Testing the Efficacy of an Eye-tracking-based Treatment in Reducing Stress-related Symptoms in Veterans With PTSD
This study is testing a new eye-tracking treatment to see if it can help veterans with PTSD feel less stressed.
Quick facts
| Phase | Phase2; Phase3 |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 20 Years to 70 Years |
| Sex | All |
| Sponsor | Tel Aviv University Academic / other |
| Locations | 1 site (Tel Aviv) |
| Trial ID | NCT05243459 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a novel eye-tracking-based treatment called Gaze-Contingent Music Reward Therapy in reducing stress-related symptoms in veterans diagnosed with posttraumatic stress disorder (PTSD). Participants will undergo a structured clinical assessment to confirm eligibility and will then engage in computerized tasks to measure their attention bias before receiving treatment. The study compares the eye-tracking intervention to a traditional attention bias modification approach and a control group. The goal is to determine if altering gaze patterns can positively impact PTSD symptoms.
Who should consider this trial
Good fit: Ideal candidates are veterans aged 20-70 who have a diagnosis of PTSD related to military service.
Not a fit: Patients with psychotic or bipolar disorders, substance abuse issues, or those at high risk of self-harm may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide veterans with a new, effective method to alleviate PTSD symptoms and improve their quality of life.
How similar studies have performed: While the approach is innovative, similar studies using attention bias modification have shown promise, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of PTSD according to the DSM-5 and related to military service, ages 20-70 Exclusion Criteria: * Psychotic or Bipolar disorder, drug and alcohol abuse, high risk of harming self or others, other psychological treatment, vision problems that are not overcome with regular glasses, physical disability that prevents ability to operate computer.
Where this trial is running
Tel Aviv
- Tel Aviv University — Tel Aviv, Israel (Recruiting)
Study contacts
- Principal investigator: Yair Bar-Haim, PhD — Tel Aviv University
- Study coordinator: Yair Bar-Haim, PhD
- Email: yair1@post.tau.ac.il
- Phone: +972-3-6405465
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.